Eyes on New Product Development.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 4, p. 171, doi. 10.1089/jop.2025.0073
- By:
- Publication type:
- Article
Works matching IS 10807683 AND DT 2025 AND VI 41 AND IP 4
Results: 7
1
2
DOCK1/ELMO1/Rac1 Signaling is Essential for Vitreous-Induced Migration and Contraction of ARPE19 Cells.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 4, p. 217, doi. 10.1089/jop.2024.0173
- By:
- Publication type:
- Article
3
Corticosteroid as Treatment in Infective Conjunctivitis: A Systematic Literature Review and Meta-Analysis.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 4, p. 187, doi. 10.1089/jop.2024.0110
- By:
- Publication type:
- Article
4
Safety and Efficacy of 0.1% Cyclosporine Solutions in Dry Eye Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 4, p. 199, doi. 10.1089/jop.2024.0169
- By:
- Publication type:
- Article
5
Lotilaner for Demodex Blepharitis: The Journey from Veterinary Use to Human Medicine.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 4, p. 173, doi. 10.1089/jop.2024.0145
- By:
- Publication type:
- Article
6
Letter: Effect of Aqueous Tears on Topical Fluorescein Tracer Emission Signal from Cornea and Anterior Chamber.
- Published in:
- 2025
- By:
- Publication type:
- Letter
7
Clinical Results of the Use of a Combined Solution of 0.5% Carboxymethylcellulose, 0.9% Glycerin, and 3% Trehalose for the Treatment of Dry Eye Disease.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 4, p. 210, doi. 10.1089/jop.2024.0115
- By:
- Publication type:
- Article